Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin
{{output}}
Background: Sitagliptin is a highly selective dipeptidyl peptidase-4 inhibitor for the treatment of patients with type 2 diabetes. Sitagliptin is primarily excreted by renal elimination as unchanged drug, with only a small percen... ...
